You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AXL/MER

Showing 1 - 25 of 69
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer Trial (Q702, Pembrolizumab)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • (no location specified)
Jun 27, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Los Angeles, Chicago, Morristown (Q702)

Recruiting
  • Solid Tumor
  • +2 more
  • Los Angeles, California
  • +3 more
Jul 29, 2021

Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Circulating Tumor Cell Trial in Montpellier (Detection of

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
  • Montpellier, France
    CHU Montpellier
Jul 1, 2022

Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome, Low-risk Myelodysplastic Syndrome Trial in France, Germany,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Nantes, Nantes Cedex 1, France
  • +7 more
Dec 20, 2021

Advanced Solid Tumors Trial in Worldwide (INCB081776, INCMGA00012)

Recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +19 more
Nov 10, 2022

Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)

Not yet recruiting
  • Metastatic Cervical Cancer
  • (no location specified)
Jan 31, 2023

Tumor Metastasis Trial in Worldwide (PF-07265807, Sasanlimab, Axitinib)

Recruiting
  • Neoplasm Metastasis
  • Fayetteville, Arkansas
  • +33 more
Aug 20, 2022

Renal Cell Carcinoma Trial (Cabozantinib, Ipilimumab, Nivolumab)

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jun 9, 2022

Brain and CNS Tumors Trial in United States (BGB 324 (before surgery), BGB 324 (after surgery))

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • BGB 324 (before surgery)
  • BGB 324 (after surgery)
  • Birmingham, Alabama
  • +5 more
Dec 1, 2022

Metastatic Renal Cell Carcinoma Trial in France (Cabozantinib)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • Angers, France
  • +8 more
Dec 5, 2022

PD - Parkinson's Disease, Dexmedetomidine, Desflurane Trial in Beijing (general anesthesia, Conscious sedation)

Not yet recruiting
  • PD - Parkinson's Disease
  • +3 more
  • general anesthesia
  • Conscious sedation
  • Beijing, China
    Beijing Tiantan Hospital, Capital Medical University
Oct 20, 2022

Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

Recruiting
  • Refractory Cutaneous Melanoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 8, 2022

Advanced or Metastatic Solid Tumors Trial in San Antonio (RXDX-106)

Terminated
  • Advanced or Metastatic Solid Tumors
  • San Antonio, Texas
    START
Apr 24, 2019

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Tianjin (NTQ2494 tablet)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • NTQ2494 tablet
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 17, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Complicated Intra-abdominal Infection, Hosptial Acquired Pneumonia, Ventilator Associated Pneumonia Trial in Worldwide (ATM-AVI,

Recruiting
  • Complicated Intra-abdominal Infection
  • +2 more
  • Tucson, Arizona
  • +152 more
Jan 20, 2023

Mer-TK in Human Cardiac Cells

Completed
  • Myocardial Inflammation
  • Myocardial Infarction
  • Change in Soluble MER Concentration
  • Chicago, Illinois
    Ann & Robert H Lurie Children's Hopsital
Aug 10, 2021

Non-Small-Cell Lung Cancer Trial in Hong Kong, Taiwan, United States (CAB-AXL-ADC, PD-1 inhibitor)

Recruiting
  • Non-Small-Cell Lung Cancer
  • CAB-AXL-ADC
  • PD-1 inhibitor
  • Duarte, California
  • +34 more
Jul 11, 2022

Parkinson Disease Trial in France (Surgery under general anesthesia with experimental targeting, Usual Surgery)

Recruiting
  • Parkinson Disease
  • Surgery under general anesthesia with experimental targeting
  • Usual Surgery
  • Amiens, France
  • +9 more
May 31, 2022

Chronic Lymphocytic Leukemia, CLL, SLL Trial in United States (TP-0903, TP-0903 and ibrutinib combination therapy)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • TP-0903
  • TP-0903 and ibrutinib combination therapy
  • Phoenix, Arizona
  • +5 more
Apr 4, 2022

PD - Parkinson's Disease Trial in Beijing (Dexmedetomidine)

Recruiting
  • PD - Parkinson's Disease
  • Beijing, Beijing, China
    Beijing Tiantan hospital
Jun 16, 2022

Lung Cancer, Cancer, Immunotherapy Trial in Guangzhou (CAR-T cells targeting PSCA, MUC1, TGFß, HER2, Mesothelin, Lewis-Y, GPC3,

Recruiting
  • Lung Cancer
  • +3 more
  • CAR-T cells targeting PSCA, MUC1, TGFβ, HER2, Mesothelin, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2, or B7-H3
  • Guangzhou, Guangdong, China
  • +1 more
Nov 26, 2021

NSCLC Trial in United States (erlotinib, bemcentinib)

Completed
  • Non-Small Cell Lung Cancer
  • Los Angeles, California
  • +9 more
Aug 16, 2022

Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial (AVB-S6-500, Paclitaxel, Carboplatin)

Withdrawn
  • Epithelial Ovarian Cancer
  • +2 more
  • (no location specified)
Sep 23, 2021

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

Recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of Head and Neck
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Apr 24, 2023